Astrocytoma
90
14
21
41
Key Insights
Highlights
Success Rate
76% trial completion
Published Results
16 trials with published results (18%)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.4%
13 terminated out of 90 trials
75.9%
-10.7% vs benchmark
6%
5 trials in Phase 3/4
39%
16 of 41 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 41 completed trials
Clinical Trials (90)
Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Treated With Cesium-131 GammaTile®
Insights Into the Pathophysiology of Neurovascular Uncoupling in Patients With Brain Lesions.
FearLess in NeuroOncology
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Study of Olutasidenib and Temozolomide in HGG
Pediatric Long-Term Follow-up and Rollover Study
Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma
Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
Social Determinants of Health in Glioblastoma Population
Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases
GliomaAI-Astro4: MRI-Based Detection of IDH Mutant Astrocytoma Grade 4
GliomaAI-Astro23: MRI-Based Detection of IDH Mutant Astrocytoma (Grade 2 and 3)
Astrocytoma / Desmoplastic Gamliogliomes (DIA / DIG) - Study of the French Cohort of the Last 20 Years : Clinical, Anatomopathological, Molecular and Radiological Charactersics
First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
Investigational Imaging Technique During Brain Surgery
Tuvusertib in Astrocytoma With ATRX Mutation
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas